Advanced search

Filters

Country

All countries

North America

South America

Europe

Africa

Middle East

Asia

Oceania

Central America

Select all

Capitalization

Sector

All sectors

  Energy

  Basic Materials

  Industrials

  Consumer Cyclicals

  Consumer Non-Cyclicals

  Financials

  Healthcare

  Technology

  Utilities

  Real Estate

  Institutions, Associations & Organizations

  Government Activity

  Academic & Educational Services

Select all

Add a keyword

Announcement Date

Since

Until

289 Results

Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Stryker : 2023 Comprehensive Report
PU
Transcript : Stryker Corporation, Q4 2023 Earnings Call, Jan 30, 2024
Stryker reports 2023 operating results and 2024 outlook
GL
Stryker announces 2023 sales surpassed $20 billion
GL
Quest Resource Holding Corporation Achieves 96% Food Waste Diversion Using Newly Patented Quest Proganics®
AQ
Stryker announces intention to nominate a new director, Rachel Ruggeri
GL
Stryker announces Dr. Srikant Datar will retire from Board of Directors
GL
Stryker announces Dr. Srikant Datar will retire from Board of Directors
AQ
Stryker declares a $0.80 per share quarterly dividend
GL
Transcript : Stryker Corporation - Analyst/Investor Day
Transcript : Stryker Corporation, Q3 2023 Earnings Call, Nov 02, 2023
Stryker reports third quarter 2023 operating results
GL
Transcript : Parker-Hannifin Corporation - Shareholder/Analyst Call
Transcript : Stryker Corporation, Q2 2023 Earnings Call, Aug 03, 2023
Stryker reports second quarter 2023 operating results
GL
Stryker reports second quarter 2023 operating results
AQ
Transcript : Stryker Corporation - Special Call
Transcript : Alaunos Therapeutics, Inc., Q1 2023 Earnings Call, May 10, 2023
Transcript : Stryker Corporation, Q1 2023 Earnings Call, May 01, 2023
Stryker reports first quarter 2023 operating results
GL
Transcript : Wishpond Technologies Ltd. - Analyst/Investor Day
Stryker Seeks Mergers and Acquisitions
CI
Transcript : Stryker Corporation, Q4 2022 Earnings Call, Jan 31, 2023
Stryker reports 2022 operating results and 2023 outlook
AQ
Stryker reports 2022 operating results and 2023 outlook
GL
Stryker declares a $0.75 per share quarterly dividend
GL
Transcript : Stryker Corporation Presents at 5th Annual Evercore ISI HealthCONx Conference 2022, Dec-01-2022 08:50 AM
Wishpond Launches Braxy.io - an AI powered Google Ads Solution
PR
Transcript : Alaunos Therapeutics, Inc., Q3 2022 Earnings Call, Nov 14, 2022
Stryker to participate in the 5th Annual Evercore ISI HealthCONx Conference
GL
Transcript : Stryker Corporation, Q3 2022 Earnings Call, Oct 31, 2022
Stryker reports third quarter 2022 operating results
GL
Stryker reports third quarter 2022 operating results
GL
PARKER HANNIFIN CORP : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
Transcript : Parker-Hannifin Corporation - Shareholder/Analyst Call
Alaunos Therapeutics : Reports Second Quarter 2022 Financial Results - Form 8-K
PU
Alaunos Therapeutics : Appoints Abhishek Srivastava, Ph.D. as Vice President, Technical Operations - Form 8-K
PU
Transcript : Stryker Corporation, Q2 2022 Earnings Call, Jul 26, 2022
STRYKER : REPORTS SECOND QUARTER 2022 OPERATING RESULTS - Form 8-K
PU
Stryker reports second quarter 2022 operating results
GL
Stryker reports second quarter 2022 operating results
AQ
Alaunos Therapeutics : and the National Cancer Institute Extend Cooperative Research and Development Agreement for Development of Personalized TCR-T Cell Therapies To 2025 - Form 8-K
PU
Alaunos Therapeutics to Present at the Jefferies Healthcare Conference
AQ
Alaunos Therapeutics to Present Trials in Progress Poster for its TCR-T Library Phase 1/2 trial at the 2022 American Society of Clinical Oncology Annual Meeting
AQ
Transcript : Alaunos Therapeutics, Inc., Q1 2022 Earnings Call, May 16, 2022
Alaunos Therapeutics Reports First Quarter 2022 Financial Results
AQ
STRYKER CORP : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
STRYKER CORP : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
Stryker announces board changes following Annual Meeting of Shareholders
GL
Alaunos Therapeutics : Doses First Patient in TCR-T Library Phase 1/2 trial for the Treatment of Patients with Solid Tumors - Form 8-K
PU
No results for this search
  1. Stock Market
  2. Advanced search
  3. Kevin Lobo
  4. News